Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States

By M. Richards, J. Edwards, D. Culver, R. Gaynes. Infection Control & Hospital Epidemiology, 2000

1,060 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Infectious Diseases, Surgery

View Paper: https://www.semanticscholar.org/paper/7fccdc05cbc8f97e4276258a7742a7228e513390

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

1. E. Kojic

In Infectious Diseases

1. E. Kojic
2. L. Chiarello
3. J. Siegel
4. M. Jackson
5. R. Darouiche
6. E. Rhinehart

Citations in the corpus

• Genomic islands: tools of bacterial horizontal gene transfer and evolution (2008, background): “Enterococcus faecalis is also one of the leading agents of nosocomial infections of surgical sites, the urinary tract and bloodstream (Richards et al., 2000).”
• Candida Infections of Medical Devices (2004, background): “albicans accounts for up to 63% of all cases of candidemias (32, 96), followed by C.”
• Clinical and economic consequences of ventilator-associated pneumonia: A systematic review (2005, neutral): “Cook, 1998 (41) 48 hrs 1,014 177 (17) Clinical and PSB/BAL Medical ICU Papazian, 1996 (42) 48 hrs 586 97 (17) Clinical and PSB/BAL Medical-surgical ICU Memish, 2000 (43) Any 202 41 (20) Clinical Medical-surgical ICU Ibrahim, 2001 (44) Any 880 132 (15) Clinical Medical-surgical ICU Rello, 2002 (45) 2”
• Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae (2018, background): “Klebsiella species are also a leading cause of ventilator-associated pneumonia (VAP) among patients in intensive care units (ICUs) (Kalanuria et al., 2014; Selina et al., 2014), and VAP is responsible for 83% of hospital-acquired (HA) pneumonias (Richards et al., 2000).”
• 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings (2007, background): “A key issue is the use of ASC in control efforts and preemptive use of contact precautions pending negative surveillance culture results.(107,321,322) The various guidelines currently available exhibit a spectrum of approaches, which their authors deem to be evidence based.”